Neuland Laboratories

Neuland Laboratories has over 30 years of experience in the development and cGMP manufacturing of APIs. The company supports global pharmaceutical and biotech clients with custom synthesis and contract manufacturing services for both small molecules and peptides. It operates three US FDA/EU GMP-compliant facilities in India with a strong track record in process chemistry and regulatory support. As of 2024 it supplies more than 100 APIs across 10 therapy areas globally. Its CMS/CDMO business has grown rapidly—now accounting for nearly half its revenue—and focuses on high-value specialty APIs including peptides. The company’s pipeline includes both generic prime segment molecules as well as differentiated specialty APIs; it also works confidentially on innovator pipelines via its CMS business.